Clinical trial
MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex…
NCT00180401 · Boston Scientific Corporation, Industry · Terminated
Key facts
| NCT number | NCT00180401 |
|---|---|
| Title | MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms |
| Official title | MODULA-Study: Modul 10: Benefit of CRT-therapy in CRT-Patients With QRS-complex of 120 - 150 ms |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Collaborators | Guidant Corporation Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Heart Failure |
| Intervention type | Behavioral |
| Interventions | CRT-P and CRT-D devices |
| Enrollment | 100 |
| Start date | Jun 1, 2002 |
| Completion | Oct 1, 2007 |
| First posted | Sep 16, 2005 |
| Last update posted | Feb 23, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: